Additional information
| Trade Name | AASAB |
|---|---|
| Generic Name | Sorafenib |
| Manufacturer | BSA Tradex Pvt. Ltd. |
| Drug Type | Oncology |
| Indication | Kidney Cancer |
| Doasage Form | Tablet |
| Packaging | 1 X 120 Cytotoxic 200mg |
AASAB (Sorafenib)-200mg
A kinase inhibitor AASAB (Sorafenib) works by blocking chemical messengers (called kinases) which send signals to cells to grow. It also prevents the cancer from developing the blood vessels which it needs in order for its cells to grow. Together, these actions slow down the spread of cancer cells.
Is used for the treatment of
- Advanced renal cell cancer
- Hepatocellular carcinoma (HCC)
- Thyroid cancer
